Reducing needle pain—particularly in pediatric and acute care environments—continues to be a priority for clinicians across Canada. From emergency departments to vaccination clinics, healthcare teams are actively seeking non-pharmacological solutions that improve the patient experience without adding complexity to clinical workflows.

Recent research published this quarter adds to the growing body of evidence supportingBuzzy®, a reusable, drug-free pain reduction device used during injections and venipuncture.

What’s new in the evidence?

Four newly published, peer-reviewed studies evaluated Buzzy’s effectiveness across real-world clinical settings, including pediatric emergency departments and routine venipuncture. Collectively, these studies reinforce Buzzy’s role as a practical, evidence-backed option for procedural pain management.

Key findings clinicians may find relevant include:

• Consistent reductions in patient-reported pain without medication
• Proven effectiveness for vaccinations and IV starts
• New guidance on optimal placement, including deltoid injections
• Strong outcomes in pediatric populations, particularly children aged 7 and older

These findings are especially meaningful for teams focused on patient-centered care, quality improvement initiatives, and minimizing distress during routine but often anxiety-provoking procedures.

Supporting real-world clinical adoption

Beyond the clinical data, what continues to resonate with Canadian healthcare teams is Buzzy’s simplicity. The device integrates easily into existing protocols, requires minimal training, and can be reused across patients—making it well suited for fast-paced acute care environments.

As your Canadian distributor,AHS Inc.supports healthcare organizations not only with product access, but also with:

• Clinical education and training resources
• Support for protocol alignment and implementation
• Ongoing consultation to ensure solutions fit the realities of frontline care

Moving toward evidence-informed standards of care

The expanding research around non-pharmacological pain reduction reflects a broader shift in healthcare: small, practical interventions can have a meaningful impact on patient experience when supported by strong clinical evidence.

For teams reviewing pain management strategies—or looking to enhance existing practices—these recent studies provide valuable insights into how vibration and cold therapy can play a role in modern acute care.

If you’re interested in learning more about the published research, clinical application, or how Buzzy is being used across Canadian healthcare settings, we’re always happy to continue the conversation.

Clinical References

1. Andrews, T. J., Fennell, J., Wrotniak, B. H., & Territo, H.The effectiveness of a gate control device on pain in the pediatric emergency department: A randomized controlled trial.Pediatric Emergency Care, 2023.link.
2. Baxter, A. L., et al.Reducing vaccination pain using multidermatomal versus deltoid placement of vibration and cold therapy: A randomized controlled study.Clinical Pediatrics, 2024.link.
3. Baxter, A. L., et al.Toward age-specific application of pediatric non-pharmacological pain strategies: A Bayesian reanalysis of the Buzzy® device.Pain Management, 2024.link.
4. Baxter, A. L., et al.A multidimensional assessment of vibration and cold for venipuncture pain in children aged 7 years and older: A randomized controlled trial.Journal of Pediatric Nursing, 2024.link.